ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Discovery of novel 2-aryl-4-bis-amide imidazoles (ABAI) as anti-inflammatory agents for the treatment of inflammatory bowel diseases

Li, Ling; Yuan, Sijie; Lin, Lin; Yang, Fang; Liu, Ting; Xu, Chenglong; Zhao, Huiting; Chen, Jingxuan; Kuang, Peihua; Chen, Ting*; Liao, Wenzhen*; Chen, Jianjun南方医科大学
Bioorganic Chemistry2022-3DOI: 10.1016/j.bioorg.2022.105619
3被引4阅读
引用收藏
分享

摘要

A series of 2-Aryl-4-Bis-amide Imidazoles (ABAI-1 to 30) were designed as anti-inflammatory agents. These compounds were synthesized and evaluated for the in vitro anti-inflammatory activities (inhibition of NO production and release of inflammatory cytokines). Several compounds effectively inhibited NO production in lipopolysaccharide (LPS) induced RAW264.7 cells. Among them, ABAI-30 exhibited the highest NO-inhibitory effect (inhibition rate of 87% at 20 mu M). The anti-inflammatory mechanism of ABAI-30 was examined and found to be inhibiting the TLR4-pp65 and NLRP3-caspase-1 signaling pathway, thus leading to the down regulation of IL6, IL-113 and TNF alpha at both transcriptional and translational levels. Importantly, ABAI-30 demonstrated high in vivo anti-inflammatory efficacy in a dextran sulfate sodium (DSS)-induced colitis mouse model without causing obvious toxicity. Collectively, our study provides a potent anti-inflammatory agent, which deserves further investigation as a novel therapeutic candidate for treating inflammatory bowel diseases.

学科与关键词

关键词
Anti-inflammatoryInflammatory Bowel Diseases (IBD)2-Aryl-4-bis-amide imidazoles (ABAI)
相关
加载中…
  • Discovery of novel 3-hydroxyandrosta-5,7-Diene-17-Carboxylic acid derivatives as anti-inflammatory bowel diseases (IBD) agents
    Chen, Jingxuan; Li, Ling; Liu, Jin; Yuan, Sijie; Liao, Wenzhen; Slominski, Andrzej T.; Li, Wei; Zmijewski, Michal A.; Chen, JianjunEuropean Journal of Medicinal Chemistry, 2021, 220: 113468.被引 7
  • Imidazopyrazines as New Anti-inflammatory Agents: Discovery and Biological Activity Research in vitro and in vivo
    Lai, Qingfu; Li, Tong; Zhang, Fuli; Li, Ming; Mei, Qinghua*; Ye, Lianbao*ChemistrySelect, 2022, 7(15): e202104531.被引 1
  • Anemoside B4 protects against chronic relapsing colitis in mice by modulating inflammatory response, colonic transcriptome and the gut microbiota
    Han, Qian; Deng, Li-rong; Zou, Min; Tang, Hua-zheng; Huang, Chang-yin; Chen, Fang-jun; Tomlinson, Brian; Li, Yan-hong*PHYTOMEDICINE, 2022, 106: 154416.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
Bioorganic Chemistry
发表日期
2022-03
卷期
第 120 卷
页码
105619
DOI
10.1016/j.bioorg.2022.105619
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
scientific research project of high level talents in Southern Medical University of China [C1051008]; Thousand Youth Talents Program from the Organization Department of the CPC Central Committee, China [C1080092]; International Science and Technology Cooperation Projects of Guangdong Province [G819310411]

作者

  • L

    Li, Ling (第一作者)

    new · southern med univ

  • Y

    Yuan, Sijie

    southern med univ

查看全部 12 位作者收起作者
  • L

    Lin, Lin

    southern med univ

  • Y

    Yang, Fang

    new · southern med univ

  • L

    Liu, Ting

    new · southern med univ

  • X

    Xu, Chenglong

    new · southern med univ

  • Z

    Zhao, Huiting

    new · southern med univ

  • C

    Chen, Jingxuan

  • K

    Kuang, Peihua

    new · southern med univ

  • C

    Chen, Ting (通讯)

    southern med univ

  • L

    Liao, Wenzhen (通讯)

    southern med univ

  • C

    Chen, Jianjun

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417